Small bowel transplant for advanced pseudomyxoma peritonei
Treatments studied
Part of Cancer clinical trials.
This study tests whether transplanting the small intestine (and sometimes other organs) can help people with advanced pseudomyxoma peritonei (PMP) that cannot be removed with surgery. It aims to provide a potential cure when other options are exhausted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pseudomyxoma peritonei (PMP), a type of cancer that spreads along the lining of the belly.
- Your cancer is extensive and cannot be fully removed with standard surgery.
- The cancer has not spread beyond your belly (except possibly to the lungs).
- You are between 18 and 75 years old.
- You are in generally good health (able to care for yourself) and do not have serious heart, lung, or other health problems.
- You are willing to undergo a transplant and take immunosuppressive medicines after the transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a chemotherapy combination (capecitabine and cyclophosphamide) given before surgery for people with a large amount of pseudomyxoma peritonei (PMP). The goal is to see if it can shrink the tumor and make surgery more effective.
This trial tests a vaccine for people with a rare abdominal cancer called pseudomyxoma peritonei (PMP) that has come back or cannot be removed by surgery. The vaccine is designed to help the immune system fight the cancer. It is for people whose tumor has a specific genetic change (GNAS mutation) and who have no other standard treatment options.
This trial compares a lower dose of heated chemotherapy (HIPEC) given during surgery to a standard dose for patients with pseudomyxoma peritonei (a condition where jelly-like mucus builds up in the abdomen). The goal is to see if the lower dose works just as well with fewer side effects.
This trial tests whether the drug metformin (a common diabetes pill) can help control pseudomyxoma peritonei, a rare abdominal cancer. It is for people whose cancer has come back or cannot be surgically removed, and who aren't planning a major surgery with heated chemotherapy at this time.
This trial compares two different schedules of heated chemotherapy (HIPEC) after surgery for pseudomyxoma peritonei (a rare appendix cancer that spreads in the abdomen). It may help determine whether one or three cycles of HIPEC is better for controlling the disease.
This study looks at how cancers that spread along the belly lining (“peritoneal surface malignancies”) behave and how different treatment strategies may work. It may help improve how doctors select and test treatments for people who are candidates for CRS-HIPEC, a specific cancer surgery approach.
Hear when a new Pseudomyxoma Peritonei trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.